Maximum quantity allowed is 999
Please select the quantity
CAS RN: 150399-21-6 | Product Number: B4121
Balsalazide Disodium Salt Dihydrate
×
![]()
×
Purity: >98.0%(HPLC)(N)
Synonyms:
- 5-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic Acid Disodium Salt Dihydrate
Product Documents:
| Size | Unit Price | Shanghai | Tianjin | Japan* |
|---|---|---|---|---|
| 5G |
¥1,340.00
|
1 | 1 | Contact Us |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
| Product Number | B4121 |
| Purity / Analysis Method | >98.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__1__7H__1__3N__3Na__2O__6·2H__2O = 437.32 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 150399-21-6 |
| Related CAS RN | 82101-18-6&399030-81-0 |
| PubChem Substance ID | 253659991 |
| Merck Index (14) | 945 |
| MDL Number | MFCD01631117 |
Specifications
| Appearance | Light yellow to Brown powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Water | 7.0 to 11.0 % |
| NMR | confirm to structure |
Properties (reference)
GHS
Related Laws:
Transport Information:
| Customs Control Conditions (Q) |
Application
A Pro-Drug of 5-Aminosalicylic Acid, Balsalazide
Balsalazide is the prodrug of 5-aminosalicylic acid [A0317] and 4-aminobenzoyl-beta-alanine (an inert carrier), which are released by bacterial enzymes in the colon.
References
- Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats
- I. Kimura, M. Kawasaki, S. Nagahama, A. Matsuda, M. Kataoka, Y. Kokuba, Arzneim.-Forsch. 1998, 48, 1091.
- Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine
- I. Kimura, T. Kumamoto, A. Matsuda, M. Kataoka, Y. Kokuba, Arzneim.-Forsch. 1998, 48, 1007.
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.